EMA/PE/0000241855 - paediatric investigation plan

brensocatib

Key facts

• Active substance:
  brensocatib
• Therapeutic area:
  Respiratory, thoracic and mediastinal disorders
• Decision number:
  P/0359/2024
• PIP number:
  EMA/PE/0000241855
• Pharmaceutical form(s):
  Film-coated tablet
• Condition(s) / indication(s):
  Treatment of non-cystic fibrosis bronchiectasis
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  19/03/2025
• Compliance check done:
  No

Decision

EMA/PE/0000241855: EMA decision of 19 March 2025 on the acceptance of a modification of an agreed paediatric investigation plan for brensocatib

Adopted Reference Number: EMADOC-1700519818-1977965